Abstract: The present invention provides a cosmetic shaped product: which is substantially formed with relatively low-molecular-weight hyaluronic acid or a water-soluble salt thereof having a high penetrability into the skin; which is easily soluble to water; and which has satisfactory handling properties, and a method for producing the cosmetic shaped product. There is provided a cosmetic shaped product being a sponge-like shaped body formed with at least one polyanionic polysaccharide of hyaluronic acid and a water-soluble salt thereof each having an average molecular weight of 30,000 or lower, the sponge-like shaped body having a bulk specific gravity of 5 to 500 mg/mL. This cosmetic shaped product can be produced by freeze-drying an aqueous solution having a content of the polyanionic polysaccharide of 0.5 to 30% by mass.
Type:
Grant
Filed:
October 24, 2018
Date of Patent:
October 4, 2022
Assignee:
Dainichiseika Color & Chemicals Mfg. Co., Ltd.
Abstract: The present invention relates to a shear-thinning or pseudoplastic cosmetic composition. Zeta potentials may be balanced such that a first ratio of the first zeta potential to the second zeta potential may be approximately 1:2. A second ratio of the first zeta potential to the third zeta potential may be approximately 1:2. And, a third ratio of the second zeta potential to the third zeta potential may be approximately 1:1. Balancing zeta potentials may ensure the shear-thinning cosmetic composition can dispense in its original viscous form and as a fine mist through a single device.
Abstract: The invention provides a 100% anhydrous sunscreen composition and a use of this sunscreen composition with very high water and sweat resistance properties which can be applied on a wet skin, either in the presence of water by repelling water or water droplets respectively or in under-water conditions. The present invention describes a sunscreen composition comprising a silicone organic elastomer blend comprising Dimethicone/Bis-Isobutyl PPG-20 Crosspolymer in Isododecane in a concentration range from about 30% to about 90% w/w and a silicone elastomer comprising Dimethicone/Vinyl Dimethicone Crosspolymer and Silica in a concentration range from about 0.1% to about 10% w/w. The sunscreen may be applied on the skin in the presence of water (in wet and/or under-water conditions). Further, the new sunscreen product allows the consumer to enter water directly after the application of the sunscreen product on his dry or already wet skin.
Abstract: A formed sheet product of a polymer composition comprising at least one protein selected from the group consisting of fibrinogen and thrombin and at least one polymer selected from the group consisting of an aliphatic polyester and a water-soluble polymer, and a laminated formed sheet product comprising a first polymer composition layer composed of fibrinogen and a water-soluble polymer and a second polymer composition layer composed of thrombin and an aliphatic polyester are provided. These formed products are applied onto a wound site and function as a hemostatic material.
Abstract: Combination of dry extract of Rhodiola, dry extract of Tribulus terrestris, dry extract of Undaria pinnatifida, Moringa oleifera, folic acid and vitamin B12 in the form of food supplement for mitigating woman's disorders caused by ageing.
Type:
Grant
Filed:
October 11, 2018
Date of Patent:
September 6, 2022
Assignee:
CRISTALFARMA S.R.L.
Inventors:
Maria Cristina Del Bono, Francesco Bonomo
Abstract: A dosage form with a first portion and a second portion. The first portion can be an immediate release portion and can comprise a pain reliever, which can be naproxen or naproxen sodium. The second portion can be an extended release portion and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof and/or dextromethorphan or a pharmaceutically acceptable salt thereof. The dosage form can optionally comprise a stabilizing agent. The dosage form can be adapted to maintain a therapeutically effective amount of pain reliever, pseudoephedrine, or a pharmaceutically acceptable salt thereof, and/or dextromethorphan, or a pharmaceutically acceptable salt thereof, for at least eight hours.
Type:
Grant
Filed:
December 16, 2019
Date of Patent:
September 6, 2022
Assignee:
The Procter & Gamble Company
Inventors:
Mark Edward Stella, John Richard Entwisle, Baltej Ludher, Jonathan E. Clark, Daren K. Anness, Guhan Balan, Andrew Nicholas Carr
Abstract: The invention relates to a method for enriching protists with lipids rich in polyunsaturated fatty acids (PUFA) in particular of the omega 3 (?3) class, said method comprising the culture of protists in a culture medium comprising a selenium-containing compound as well as the protists enriched with lipids rich in PUFA obtained by this method. The invention also relates to a method for producing lipids rich in PUFA, comprising, after the enrichment method according to the invention, a method for treating the protists by extraction from the biomass of selenium-containing lipids rich in PUFA. The invention finally relates to any food, cosmetic or pharmaceutical product comprising either selenium-containing lipids thus extracted, or selenium-containing biomass originating from the enrichment method.
Abstract: The present invention relates to settable compositions for use in surgery. The invention also provides related compositions, including surgical kits and packages, as well as methods of making and using the settable compositions.
Type:
Grant
Filed:
October 30, 2019
Date of Patent:
August 30, 2022
Assignee:
Abyrx, Inc.
Inventors:
John Pacifico, Aniq Darr, Richard L. Kronenthal
Abstract: The invention relates to a surface-modified effect pigment comprising particular additives and to the production thereof. The present invention further provides a nail varnish composition comprising a) at least one effect pigment that has been surface-modified with a starting material (additive), where the effect pigment comprises a substrate in platelet form and optionally at least one coating applied to the substrate, b) at least one hydrocarbon resin as binder, and c) at least one solvent or solvent mixture, where the starting material (additive) for surface modification of the effect pigment is at least one compound taken from the group consisting of phosphoric ester-containing, phosphonic ester-containing, phosphonic acid-containing, fatty acid-containing and/or silane-containing compounds or mixtures thereof.
Type:
Grant
Filed:
June 23, 2020
Date of Patent:
July 5, 2022
Assignee:
ECKART GmbH
Inventors:
Christine Schilling, Ulrich Schmidt, Christina Pippinger, Ann-Katrin Gebhard
Abstract: The present invention relates to a composition for dyeing keratin fibres comprising at least one aqueous dispersion of particles of hybrid film-forming hydrophobic acrylic polymer, at least one linear block silicone copolymer and at least one pigment. It also relates to a dyeing method in which said composition is applied to the keratin fibres, the operation optionally being followed by a drying operation. The composition makes it possible to obtain a coloured, shampoo-resistant coating that leaves the treated fibres individualized, with an improved cosmetic feel.
Abstract: The claimed subject matter relates to Lactobacillus paracasei-derived extracellular vesicles and a use thereof, and more particularly, to a composition for alleviating, preventing and treating an ocular disease, which includes Lactobacillus paracasei-derived extracellular vesicles as an active ingredient, capable of effectively inhibiting the occurrence of an ocular disease caused by oxidative stress-mediated cell senescence.
Abstract: The present invention relates to a method for the cosmetic treatment of keratin materials, comprising the application of a composition to the keratin materials, such as the skin, said composition comprising a compound (I), wherein R1, R2 and R3 are as defined in the description and S* is a mono or polysaccharide.
Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
Abstract: The present disclosure relates to methods, systems and kits for treating the skin by applying onto the skin a skin tightening composition comprising 1) at least one thermoplastic elastomer and at least one adhesive polymer; and 2) a sunscreen composition comprising one or more UV filters. Methods, systems and kits comprise applying the compositions of the systems sequentially.
Type:
Grant
Filed:
September 28, 2018
Date of Patent:
May 3, 2022
Assignee:
L'OREAL
Inventors:
Brian Scott Bodnar, Anne-Laure Suzanne Bernard, Anil Shah, Alexandra Jane Elisa Farran
Abstract: Methods of reducing hepatitis delta virus (HDV) viral loads in a patient are provided. In some embodiments, the method comprises treating the patient with lonafarnib-ritonavir co-therapy. In some embodiments, the method further comprises treating the patient with an interferon.
Type:
Grant
Filed:
August 18, 2020
Date of Patent:
April 26, 2022
Assignee:
Eiger BioPharmaceuticals, Inc.
Inventors:
David A. Cory, Ingrid Choong, Jeffrey S. Glenn
Abstract: The present invention relates to a transparent or semitransparent cosmetic composition in which the stability of amentoflavone is enhanced, and more particularly, to a transparent or semitransparent cosmetic composition, wherein a water-soluble amentoflavone-oligomer complex, in which amentoflavone is encapsulated in a hollow structure of an oligomer structure, is stabilized in a second agent containing a polyhydric alcohol, a two-liquid-type container is used to mix first and second agents before use, and hydrotrope is contained in the first agent to increase the mixing stability of the first and second agents and thereby enhance the stability of amentoflavone.
Type:
Grant
Filed:
March 26, 2018
Date of Patent:
April 12, 2022
Assignee:
Amorepacific Corporation
Inventors:
Byung Ryol Paik, Soon Ae An, Joon Young Hwang, Yong Jin Kim, Byung Fhy Suh
Abstract: A cosmetic mask composition including a combination of acrylates/VA copolymer and acrylates copolymer. The cosmetic mask composition includes about 5% to 30% by weight of acrylates/VA copolymer, and about 0.2% to 2% by weight of acrylates copolymer. The ratio of acrylates/VA copolymer to acrylates copolymer is in the range of 15:1 to 25:1.
Type:
Grant
Filed:
March 12, 2020
Date of Patent:
April 5, 2022
Assignee:
ELC Management LLC
Inventors:
Fatemeh Mohammadi, Sunni L. Tejada, Lisa Qu, Anna Czarnota, Tsung-Wei Robert Mou, Wilson A. Lee
Abstract: A chewable pharmaceutical product comprises a matrix comprising: a binder, a bulking agent, a lubricant, a humectant, an emulsifier, and optionally a flavoring, wherein the binder comprises one or more maltitol syrups, which are present in the pharmaceutical product in an amount in the range of 60-70% by weight; and colesevelam hydrochloride.
Abstract: A method of preventing COVID-19 infection in a healthy individual, the method comprising the steps of a) providing the healthy individual; b) administering, on day 1, 10,000 mg of vitamin C, 40,000 mg of vitamin D, and 50 mg of zinc; c) administering daily, on days 2 and 3, 10,000 mg of vitamin c and 50 mg of zinc; d) administering daily, on days 4 through 7, 3,000 mg of vitamin c and 50 mg of zinc; and e) repeating steps b) and c) for 1 to 23 weeks.